{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:20:39Z","timestamp":1789993239360,"version":"4.0.1"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We developed a europium nanoparticle-based immunoassay (ENIA) for the sensitive detection of anthrax protective antigen (PA). The ENIA exhibited a linear dose-dependent pattern within the detection range of 0.01 to 100 ng\/ml and was approximately 100-fold more sensitive than enzyme-linked immunosorbent assay (ELISA). False-positive results were not observed with serum samples from healthy adults, mouse plasma without PA, or plasma samples collected from mice injected with anthrax lethal factor or edema factor alone. For the detection of plasma samples spiked with PA, the detection sensitivities for ENIA and ELISA were 100% (11\/11 samples) and 36.4% (4\/11 samples), respectively. The assay exhibited a linear but qualitative correlation between the PA injected and the PA detected in murine blood (\n            <jats:italic>r<\/jats:italic>\n            = 0.97731;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). Anthrax PA was also detected in the circulation of mice infected with spores from a toxigenic Sterne-like strain of\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            , but only in the later stages of infection. These results indicate that the universal labeling technology based on europium nanoparticles and its application may provide a rapid and sensitive testing platform for clinical diagnosis and laboratory research.\n          <\/jats:p>","DOI":"10.1128\/cvi.00412-08","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T02:36:20Z","timestamp":1231382180000},"page":"408-413","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":92,"title":["Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles"],"prefix":"10.1128","volume":"16","author":[{"given":"Shixing","family":"Tang","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Moayeri","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochun","family":"Chen","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Harma","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Hu","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Purcell","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira K.","family":"Hewlett","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"},{"name":"Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Laboratory of Biophysics, University of Turku, Turku FIN-20520, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","volume":"160","year":"2003","unstructured":"Abrami, L., S. Liu, P. Cosson, S. H. Leppla, and F. G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol.160:321-328.","journal-title":"J. Cell Biol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CDLI.11.1.50-55.2004","volume":"11","year":"2004","unstructured":"Biagini, R. E., D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. Striley, V. Semenova, E. Steward-Clark, K. Stamey, A. E. Freeman, C. P. Quinn, and J. E. Snawder. 2004. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin. Diagn. Lab. Immunol.11:50-55.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.13.5.541-546.2006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/500148","volume":"193","year":"2006","unstructured":"Chen, Z., M. Moayeri, Y. H. Zhou, S. Leppla, S. Emerson, A. Sebrell, F. Yu, J. Svitel, P. Schuck, M. St. Claire, and R. Purcell. 2006. Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J. Infect. Dis.193:625-633.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/1522-7243(200011\/12)15:6<351::AID-BIO624>3.0.CO;2-3","volume":"15","year":"2000","unstructured":"Harma, H., T. Soukka, S. Lonnberg, J. Paukkunen, P. Tarkkinen, and T. Lovgren. 2000. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence. Luminescence15:351-355.","journal-title":"Luminescence"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.3.561"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0003-2697(84)90095-2","volume":"137","year":"1984","unstructured":"Hemmila, I., S. Dakubu, V. M. Mukkala, H. Siitari, and T. Lovgren. 1984. Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem.137:335-343.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1462-5822.2006.00738.x","volume":"8","year":"2006","unstructured":"Hu, H., Q. Sa, T. M. Koehler, A. I. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell. Microbiol.8:1634-1642.","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2004.09.002","volume":"294","year":"2004","unstructured":"Huhtinen, P., T. Soukka, T. Lovgren, and H. Harma. 2004. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology. J. Immunol. Methods294:111-122.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","volume":"7","year":"2001","unstructured":"Jernigan, J. A., D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, and B. A. Perkins. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis.7:933-944.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_12_2","first-page":"323","year":"2006","unstructured":"Leppla, S. 2006. Bacillus anthracis toxins, p. 323-347. In J. E. Alouf and M. R. Popoff (ed.), The comprehensive sourcebook of bacterial protein toxins. Academic Press, Burlington, MA.","journal-title":"The comprehensive sourcebook of bacterial protein toxins."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.7.1807-1813.1988"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","volume":"142","year":"1996","unstructured":"Little, S. F., J. M. Novak, J. R. Lowe, S. H. Leppla, Y. Singh, K. R. Klimpel, B. C. Lidgerding, and A. M. Friedlander. 1996. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology142(Pt 3):707-715.","journal-title":"Microbiology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","volume":"278","year":"2003","unstructured":"Liu, S., and S. H. Leppla. 2003. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem.278:5227-5234.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00023-06"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8362-8368.2005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","volume":"7","year":"2004","unstructured":"Moayeri, M., and S. H. Leppla. 2004. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol.7:19-24.","journal-title":"Curr. Opin. Microbiol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00719-07"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1021\/ja049384+","volume":"126","year":"2004","unstructured":"Nam, J. M., S. I. Stoeva, and C. A. Mirkin. 2004. Bio-bar-code-based DNA detection with PCR-like sensitivity. J. Am. Chem. Soc.126:5932-5933.","journal-title":"J. Am. Chem. Soc."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1126\/science.1088755","volume":"301","year":"2003","unstructured":"Nam, J. M., C. S. Thaxton, and C. A. Mirkin. 2003. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science301:1884-1886.","journal-title":"Science"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/prep.2000.1208","volume":"18","year":"2000","unstructured":"Park, S., and S. H. Leppla. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr. Purif.18:293-302.","journal-title":"Protein Expr. Purif."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.682-693.2006"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","volume":"8","year":"2002","unstructured":"Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene, H. Li, K. Stamey, E. Steward-Clark, D. S. Schmidt, E. Mothershed, J. Pruckler, S. Schwartz, R. F. Benson, L. O. Helsel, P. F. Holder, S. E. Johnson, M. Kellum, T. Messmer, W. L. Thacker, L. Besser, B. D. Plikaytis, T. H. Taylor, Jr., A. E. Freeman, K. J. Wallace, P. Dull, J. Sejvar, E. Bruce, R. Moreno, A. Schuchat, J. R. Lingappa, S. K. Martin, J. Walls, M. Bronsdon, G. M. Carlone, M. Bajani-Ari, D. A. Ashford, D. S. Stephens, and B. A. Perkins. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis.8:1103-1110.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/cr030067f","volume":"105","year":"2005","unstructured":"Rosi, N. L., and C. A. Mirkin. 2005. Nanostructures in biodiagnostics. Chem. Rev.105:1547-1562.","journal-title":"Chem. Rev."},{"key":"e_1_3_2_26_2","first-page":"553","volume":"124","year":"1963","unstructured":"Schaffer, P., H. Ionesco, A. Ryter, and G. Balassa. 1963. Sporulation of Bacillus subtilis: genetic and physiological study. Colloq. Int. CNRS124:553-563.","journal-title":"Colloq. Int. CNRS"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0009-8981(02)00376-5","volume":"328","year":"2003","unstructured":"Soukka, T., K. Antonen, H. Harma, A. M. Pelkkikangas, P. Huhtinen, and T. Lovgren. 2003. Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology. Clin. Chim. Acta328:45-58.","journal-title":"Clin. Chim. Acta"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/clinchem\/47.7.1269","volume":"47","year":"2001","unstructured":"Soukka, T., J. Paukkunen, H. Harma, S. Lonnberg, H. Lindroos, and T. Lovgren. 2001. Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. Clin. Chem.47:1269-1278.","journal-title":"Clin. Chem."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31814a554b"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20061891","volume":"402","year":"2007","unstructured":"Turk, B. E. 2007. Manipulation of host signalling pathways by anthrax toxins. Biochem. J.402:405-417.","journal-title":"Biochem. J."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF03401732","volume":"4","year":"1998","unstructured":"Varughese, M., A. Chi, A. V. Teixeira, P. J. Nicholls, J. M. Keith, and S. H. Leppla. 1998. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med.4:87-95.","journal-title":"Mol. Med."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.1860-1865.1999"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.9.5978-5987.2005"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00412-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00412-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:41:48Z","timestamp":1627591308000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00412-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1128\/CVI.00412-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00412-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2008-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-12-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}